Transactie | Adres | Bedrag |
---|---|---|
7d2937...e14ca0
|
the-void |
-
6.26532428 LTC
·
396.72 USD
|
7d2937...e14ca0
|
LcNS6c...osnkN3
|
+
6.26532428 LTC
·
396.72 USD
|
7d2937...e14ca0
|
script-59bfd79dcd93469828d13d412f645f47 |
+
0 LTC
·
0.00 USD
|
4b8244...e3f418
|
ltc1q9...hqc6mm
|
-
0.75615783 LTC
·
47.87 USD
|
4b8244...e3f418
|
LZhFbH...Un7CKR
|
+
0.31407 LTC
·
19.88 USD
|
4b8244...e3f418
|
ltc1qp...e9dmcz
|
+
0.44155064 LTC
·
27.95 USD
|
4b8244...e3f418
|
the-void |
+
0.00053719 LTC
·
0.03 USD
|
f7f8c3...6cb9fe
|
ltc1q4...z4770k
|
-
29.873329 LTC
·
1,891.57 USD
|
f7f8c3...6cb9fe
|
MVWpHU...rLPuVT
|
+
0.60537 LTC
·
38.33 USD
|
f7f8c3...6cb9fe
|
ltc1qe...latyl4
|
+
29.267533 LTC
·
1,853.22 USD
|
MEI Pharma invests $100 million in Litecoin, appointing Litecoin founder Charlie Lee to the board, bridging biotech and crypto.
Litecoin stijgt met 15,5% naar $120 door bedrijfsinvesteringen en groeiende ETF-hoop.
Mei Pharma plant, $100 Millionen in Litecoin zu investieren, um es als primäres Reserve-Vermögen zu nutzen.